Syapse
OverviewSuggest Edit
Syapse drives healthcare transformation through precision medicine, enabling provider systems to improve clinical outcomes, streamline operations, and shift to new payment models. Syapse Precision Medicine Platform is a comprehensive software suite used by leading health systems to support the clinical implementation of precision medicine in oncology and other service lines. This category-defining platform enables clinical and genomic data integration, decision support, care coordination, and quality improvement at point of care.
| Type | Private | |
| Founded | 2008 | |
| HQ | San Francisco, US | Map |
| Website | syapse.com | |
| Employee Ratings | More | |
| Overall Culture | D+ | More |
Recent NewsAll News
- FDA partners with Syapse to study regulatory use of real-world evidence
- South Korea’s SNUH extends partnership with Syapse to expand access to precision medicine
- Precision Medicine Leader Syapse to Utilize NCCN Biomarkers Compendium for Clinical Care
- Predictive Genetic Testing & Consumer/Wellness Genomics Market Is Expected To Play a Seminal Role in the Ultimate Discovery of Personalized Therapies and Medicines
Key People/Management at Syapse
Ken Tarkoff
Chief Executive Officer, Director
Tony Loeser
Co-Founder & Chief Technology Officer
Jonathan Hirsch
Founder & President
David Pomerantz
Chief Commercial Officer
Thomas Brown
Chief Medical Officer
Fletcher Payne
Chief Financial Officer
Syapse Office Locations
Syapse has offices in San Francisco and Radnor
San Francisco, US (HQ)
303 2nd St tower suite 500, San Francisco
Radnor, US
Two Radnor Corporate Center, 100 Matsonford Rd #100
Syapse Financials and Metrics
Summary Metrics
Founding Date | 2008 |
Syapse total Funding | $99.6 m |
Syapse latest funding size | $30 m |
Time since last funding | 6 months ago |
Syapse investors | Safeguard Scientifics, GE Ventures, Merck Global Health Innovation Fund, Roche Venture Fund, Amgen Ventures, Ascension Ventures, Social Capital, Social Capital Partners, Medidata Solutions, Intermountain Healthcare Innovation Fund, Intermountain Ventures, Revelation Alpine, Roche Finance |
Syapse's latest funding round in May 2020 was reported to be $30 m. In total, Syapse has raised $99.6 m
Syapse Cybersecurity Score
Syapse Online and Social Media Presence
1.71k Twitter followers
Syapse has 1.71k Twitter Followers. The number of followers has increased 0.1% month over month and increased 0.4% quarter over quarter
Syapse's Trends
Twitter Engagement Stats for @Syapse
1.7k
Tweets
286
Following
1.7k
Followers
3
Tweets last 30 days
0.7
Avg. likes per Tweet
66.7%
Tweets with engagement
Syapse Company Culture
Overall Culture
D+
62/100
CEO Rating
C-
68/100
Compensation
C+
69/100
Syapse News and Updates
August 15, 2019
FDA partners with Syapse to study regulatory use of real-world evidence
The precision medicine company will work with the U.S. Food and Drug Administration to see how secure patient data can be better put to work in the development of oncology treatments.
August 07, 2019
South Korea’s SNUH extends partnership with Syapse to expand access to precision medicine
SNUH serves more than 8,000 cancer patients per year across 16 cancer specialty centres, 10 multidisciplinary cancer treatment centres, and a cancer clinical trials centre.
November 01, 2018
Precision Medicine Leader Syapse to Utilize NCCN Biomarkers Compendium for Clinical Care
PLYMOUTH MEETING, Pa., Nov. 1, 2018 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®) today announced a new agreement with Syapse, the leading precision medicine company, to expand the use of best practices in precision medicine when treating people with cancer. Syapse...
March 26, 2018
Predictive Genetic Testing & Consumer/Wellness Genomics Market Is Expected To Play a Seminal Role in the Ultimate Discovery of Personalized Therapies and Medicines
The offerings of predictive genetic testing and consumer/wellness genomics market is expected to play a seminal role in the ultimate discovery of personalized therapies and medicines. World over, several direct-to-consumer (DTC) genetic testing and healthcare providers offer genetic testing products…
December 07, 2017
VC-backed Syapse hires oncology VP
San Francisco-based Syapse, a provider of precision medicine solutions, has named Dr. Aradhana Ghosh as vice president of oncology. Ghosh is a former medical oncologist at IBM Watson Health. Syapse's backers include Social Capital, Safeguard Scientifics, Ascension Ventures, GE Ventures, Intermountai…
Syapse Frequently Asked Questions
When was Syapse founded?
Syapse was founded in 2008.
Who are Syapse key executives?
Syapse's key executives are Ken Tarkoff, Tony Loeser and Jonathan Hirsch.
How many employees does Syapse have?
Syapse has 203 employees.
Who are Syapse competitors?
Competitors of Syapse include Flatiron Health, Orion Health and ConsejoSano.
Where is Syapse headquarters?
Syapse headquarters is located at 303 2nd St tower suite 500, San Francisco, San Francisco.
Where are Syapse offices?
Syapse has offices in San Francisco and Radnor.
How many offices does Syapse have?
Syapse has 2 offices.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies